Patients were more likely to have higher five-year and overall survival rates if their state had expanded Medicaid, ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Niraparib is a “maintenance” drug approved to keep certain types of cancer from coming back, including ovarian cancer, ...

Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery.

Prostate Cancer Foundation of Australia (PCFA) and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group ...

Early detection is key to lung cancer. Dr Sudipto De details scans, biopsies, and other tests that can help identify the ...

Breast cancer is a major global health concern and is one of the most common types of cancer among women. Its early detection and effective treatment can significantly improve survival rates. Regular ...

PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2025 AND KEY EVENTS DURING THE PERIOD Financial and corporate situation Operating deficit reduced by 24% compared ...

Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...

There's growing alarm over the number of younger Australian men being diagnosed with prostate cancer, sparking pleas ...

Michigan State University scientists have pinpointed the molecular "switch" that supercharges sperm for their final sprint to ...